The majority of people – about 90% – develop relapsing/ remitting multiple sclerosis, a form of MS in which a patient’s symptoms are mostly dormant, but periodically flare. Unfortunately, remitting MS, though it offers patients much-needed relief from symptoms, is simply the disease returning to dormancy.

Relapsing/ remitting multiple sclerosis most commonly develops in people in their early twenties. Long periods of remission can make MS difficult to diagnose, especially if the initial symptoms of the disease are very mild. Patients may feel tingling or numbness, experience moments of dizziness or have occasional problems with balance. As the disease progresses, these symptoms worsen, and may include blurred vision and fatigue; in later stages, patients may suffer paralysis, tremors and loss of bladder control. These symptoms are usually accompanied by pain and inflammation.

For a doctor to make a formal relapsing/ remitting multiple sclerosis prognosis, the patient must show …

Thanks to many years of research, Relapsing Remitting Multiple Sclerosis treatment options are plentiful. An abundance of Relapsing Remitting MS treatment choices are available to reduce the occurrence of attacks, help manage MS symptoms, and to modify the progression of the disease. People diagnosed with Relapsing Remitting MS experience a series of remissions and relapses. The length of remission can range from a month to a decade. Doctors have yet to figure out why some MS patients have longer remissions than others. A good point to these remissions is that most people with MS fully recover from any symptoms they were experiencing during the relapse.

A relapse is caused when the immune system damages the outer covering on nerve cells within the brain and spinal cord. This protective sheath is designed to enable nerve cells to successfully transmit signals between the body and brain. A relapse, or an exacerbation as …